Skip to main content

Table 5 Association between demographic variables and CPs perception, practice, barrier and willingness scores

From: Opportunities for extended community pharmacy services in United Arab Emirates: perception, practice, perceived barriers and willingness among community pharmacists

Demographic characteristics of CPs

Intervals

Perception

Practice

Barriers

Willingness

Median (IQR) total score

P value

Median (IQR) total score

P value

Median (IQR) total score

P value

Median (IQR) total score

P value

Gender

Male

Female

29 (28–31)

29 (28–31)

0.287*

32 (30–33)

32 (30–38)

0.944*

54 (51–58)

55 (50–61)

0.743*

15 (15–17)

15 (14–17)

0.802*

Age

Below 30

Above or equal 30

29 (28–31)

29 (28–31)

0.112*

31 (30–39)

32 (30–34)

0.902*

55 (50–61)

54 (50–58)

0.195*

16 (14–17)

15 (15–16)

0.240*

Nationality

Local

South eastern Asia

Arab

Others

29 (27.75–29.5)

29.5 (28–31)

29 (28–31)

29 (28–32.5)

0.618**

39 (36–40)

31.5(30–39)

32 (30–38)

32 (30–32.5)

0.051**

52 (26–58)

52 (47.75–55.5)

55 (50–58)

55 (51–59.5)

0.325**

15.5 (14–18)

15 (14–17)

15 (15–17)

15 (14.5–16)

0.801**

Postgraduate certificate

Yes

No

29 (28–31)

29 (28–32)

0.287*

32 (30–38)

32 (30–35)

0.183*

53.5 (43–57.75)

55 (51–59)

0.074*

15 (14–17)

15 (15–17)

0.746*

Postgraduate qualification

No postgraduate

Diploma

Master

PhD

29 (28–32)

29 (28–30.25)

29 (28–31)

–

0.760**

32 (30–35)

31 (30–33)

33 (30–39.75)

–

0.222**

55 (51–59)

53 (46.75–57.25)

54.5 (41–58)

–

0.321**

15 (15–17)

15.5 (14.75–17)

15 (14–17)

15 (15–15)

0.945**

Pharmacy location

Main street

Shopping center

Near to medical center

Others

29 (28–31.5)

28.5 (26–31)

29 (28–30)

30 (26.5–32)

0.145**

32 (30–33)

32 (29–34.25)

38 (30–40)

30 (29–32)

0.008**

54 (50–58)

56 (52–66)

52 (26–58)

55 (50–57)

0.317**

15 (15–17)

16 (14.75–17)

15 (14–18)

15 (14–15)

0.249**

Your position in the pharmacy

Proprietor

Pharmacists in charge

Employee pharmacist

Others

–

29 (28–31)

29 (28–31)

27 (27–27)

0.452**

–

32 (30–38)

31 (30–34)

31 (31–31)

0.286**

–

53.5 (50–58)

55 (50.5–60)

55 (55–55)

0.599**

–

15 (15–17)

15 (14–17)

16 (16–16)

0.881**

Pharmacy type

Chain

Individual

29 (28–31)

29 (28–31)

0.617*

32 (30–38)

33 (30–39)

0.252*

55 (50–58)

52 (50–57)

0.633*

15 (15–17)

15 (12–17)

0.189*

Access to the internet

Yes

No

29 (28–31)

29 (26.5–35)

0.779*

32 (30–38)

30 (29–43)

0.984*

54 (50–58)

85 (75.5–94.5)

0.000*

15 (15–17)

11 (11–14.5)

0.010*

References available

Internet

BNF

MOH website

Lexicomp

Drug index

Nothing

Martindale

29 (28–31)

29 (28–32)

31 (26.5–31.5)

–

–

32 (29–35)

27 (27–27)

0.038**

32 (30–33)

33 (30–39)

32 (28–33)

40 (40–40)

–

42.5 (35–43)

29 (29–29)

0.000**

55 (50–58)

52 (50.5–57)

54 (51–57)

–

–

55.5 (26–85)

94 (94–94)

0.205**

15 (15–17)

16 (15–18)

15 (14.5–15)

–

–

14.5 (11–18)

11 (11–11)

0.011**

  1. *Mann–Whitney U test; **Kruskal–Wallis H test; Bold indicate statistically significant values
Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us